ICD-10 Coding for Lymphoma Cancer(C77.2U, C81.90, C81.90B)
Comprehensive guide to ICD-10 coding for lymphoma cancer, including Hodgkin and Non-Hodgkin types, remission coding, and documentation requirements.
Complete code families applicable to Lymphoma Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C81.90 | Hodgkin lymphoma, unspecified | Use when Hodgkin lymphoma is confirmed but not further specified. |
|
| C85.90 | Non-Hodgkin lymphoma, unspecified | Use when Non-Hodgkin lymphoma is diagnosed without specific histologic classification. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutLymphoma Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Lymphoma Cancer.
Failing to document remission status.
Impact
Clinical: Inaccurate representation of patient's current health status., Regulatory: Non-compliance with coding guidelines., Financial: Potential loss of risk adjustment factors.
Mitigation
Regularly update patient records with remission status., Use standardized templates for follow-up visits.
Using C85.90 for specific subtypes of Non-Hodgkin lymphoma.
Impact
Reimbursement: May affect DRG assignment and reimbursement rates., Compliance: Non-compliance with specificity requirements., Data Quality: Decreased accuracy in health records.
Mitigation
Ensure specific subtype is documented and coded appropriately.
Subtype Documentation
Impact
Failure to document specific lymphoma subtypes.
Mitigation
Implement mandatory review of pathology reports before coding.